Skip to content

Simplify Health Care ETF

PINKNYSE ArcaSimplifyC

$40.08−0.54 (−1.33%)

At close: Nov 2, 2026, 4:00 PM ET

Intraday session: down, 79 prints from 40.62 to 40.08. Range 40.07 to 40.73. Use the arrow keys to read each point.40.2040.3040.4040.5040.7010 AM12 PM2 PM4 PM
Expense ratio
0.51%
Fund size
$345M
1Y total return
+22.7%
Yield · Last 12 months
0.74%
Holdings
52
Avg volume · 30D
83K sh
52W range
low $32.03high $41.20
Launched
Filings
SEC EDGAR

The ETF.net PINK Grade

Based on 5 of 6 pillars

C

Score 48 out of 100

Rank
14 of 25
Six-pillar profile for PINK. Scores out of 100: Cost 46, Risk 55, Mission not scored, Tradability 49, Holdings 47, Durability 53. Strongest: Risk (55). Weakest: Cost (46). Based on 5 of 6 pillars.

Score 48 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C46 out of 100
    Rank 14 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B55 out of 100
    Rank 11 of 25
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C49 out of 100
    Rank 13 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C47 out of 100
    Rank 18 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C53 out of 100
    Rank 14 of 25

Our read on PINK

ETF.net Research

In short

CMost big health care ETFs just buy the index and sit still. PINK is a stock picker: roughly 60 U.S. names chosen bottom-up, multi-cap, growth-leaning, with room to back companies developing new medicines or cutting system costs.

Stated mandate

PINK seeks long-term capital appreciation through U.S. health care companies, using a multi-cap, fundamental bottom-up approach. It generally follows a growth strategy and may emphasize companies developing medicines or improving health-care-system cost or quality.

Why people hold it

  • Active by design: about 60 U.S. health care names picked bottom-up, not several hundred sorted by market cap. Concentration cuts both ways, but each pick actually matters here.
  • Measured against an all-cap health care benchmark, so small and mid caps are in play, not just the megacap pharma that dominates S&P 500 based sector funds like XLV and RSPH.
  • Charges 0.51%, right at the category median, which is unusual pricing for a hand-picked portfolio rather than an index feed.
  • Sits in the upper half of the broad health care sector group on our review, and pays out quarterly.

Worth knowing

  • The category's index heavyweights (VHT, FHLC, XLV) charge under a tenth of a percent. PINK's fee is roughly six times that, and it buys the manager's judgment.
  • No index to hug. Holdings come from a manager's calls, so the fund can sit far from the health care benchmark in either direction.
  • One sector, one country, about 60 holdings, growth lean. Trial results and health policy headlines land with full force here.

PINK Performance

Launched Oct 7, 2021

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
PINK$12,268
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. PINK $12,268. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PINK. Periods over one year show the average yearly return.
PeriodPINK
Year to date+11.6%
1 month+5.2%
3 months+4.6%
1 year+22.7%
3 yearsper year+20.1%
5 yearsper year+9.7%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PINK
YearReturn barPINK
2026 YTD+11.6%
2025+24.4%
2024+8.8%
2023+3.8%
2022−4.4%
2021+12.2%

History from Oct 8, 2021

PINK in the news

PINK Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.74%Last 12 months
Payout per share
$0.30Last 12 months
Last payment
$0.10 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2021–2026

One bar per payment. 20 payments from 2021 to 2026 YTD. Dec 27, 2021 $0.01; Mar 28, 2022 $0.04; Jun 27, 2022 $0.03; Sep 27, 2022 $0.03; Dec 27, 2022 $0.02; Mar 27, 2023 $0.02; Jun 27, 2023 $0.13; Sep 27, 2023 $0.03; Dec 26, 2023 $0.08; Mar 25, 2024 $0.03; Jun 25, 2024 $0.03; Sep 25, 2024 $0.02; Dec 23, 2024 $0.01; Mar 26, 2025 $0.05; Jun 25, 2025 $0.05; Sep 25, 2025 $0.05; Dec 23, 2025 $0.10; Mar 26, 2026 $0.05; Jun 25, 2026 $0.05; Sep 25, 2026 $0.10. Use the arrow keys to read each point.202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 25, 2026Sep 30, 2026$0.10
Jun 25, 2026Jun 30, 2026$0.05
Mar 26, 2026Mar 31, 2026$0.05
Dec 23, 2025Dec 31, 2025$0.10
Sep 25, 2025Sep 30, 2025$0.05
Jun 25, 2025Jun 30, 2025$0.05
Mar 26, 2025Mar 31, 2025$0.05
Dec 23, 2024Dec 31, 2024$0.01
Sep 25, 2024Sep 30, 2024$0.02
Jun 25, 2024Jun 28, 2024$0.03
Mar 25, 2024Mar 28, 2024$0.03
Dec 26, 2023Dec 29, 2023$0.08

See all 20 payments⁠

$10,000 in PINK 5 years ago paid $351 in dividends.⁠

PINK Risk

How much the fund’s monthly returns vary, scaled to a year.
16.1%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.94
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−18.8%
Trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.73
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

PINK Cost

Overpaying vs XLV, cheapest in Health Care (Broad)

$8,476

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • PINK 0.51%

    $10,165

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • PINK 0.51%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2.5K$5K$7.5K$10K$12.5K051015202530PINK $10,165XLV $1,689

Year by year

YearPINKXLVOverpaying
10$918$147$771
20$3,527$575$2,952
30$10,165$1,689$8,476

Other funds in Health Care (Broad)